Overview

Infant Colic Treatment With Probiotics

Status:
Completed

Trial end date:
2019-06-15

Target enrollment:

Participant gender:

Summary

This study evaluates the efficacy of Bifidobacterium breve CECT7263 and the mixture B. breve CECT7263/Lactobacillus fermentum CECT5716 in the treatment of infant colic. Group 1 will receive B. breve CECT7263 (2x10E8 CFU/day) one dose per day, group 2 will receive B. breve CECT7263 (1x10E8 CFU/day) and L. fermentum CECT5716 (1x10E8 CFU/day) in one dose per day, group 3 (control group) will receive simethicone 20 mg 4 times a day.

Phase:

Phase 2

Details

Lead Sponsor:

Mónica Olivares Martín
Mónica Olivares Martín; PhD

Collaborators:

European Regional Development Fund
Ministerio de Ciencia e Innovación, Spain

Treatments:

Simethicone